(RTTNews) – Evotec SE (EVOTF.PK), a biopharmaceutical company, announced Wednesday that its Seattle unit, Just – EvotecBiologics, Inc. has expanded its contract with Advanced BioScience Laboratories, Inc. to design efficient manufacturing processes for large-scale neutralization. antibodies against HIV.
Financial details of the deal have not yet been disclosed.
Under these terms, Just-Evotec Biologics will develop a third bNAb and carry out large-scale cGMP manufacturing campaigns for the current bNAb and a previously developed HIV bNAb, while providing release and stability testing services.
According to the WHO, 38 million people live with HIV worldwide.
Both companies aim to provide clinical materials to continue vital clinical trials underway around the world through this program.
On Tuesday, Evotec shares closed at 14.13 euros, up 6.64% in Germany.